glp-1 molecular weight GLP-1R protein expression in human AT. Western blot analysis of human Full-length human GLP-1 receptor structure
Description
Starting at low doses and slowly increasing over weeks to months significantly improves tolerability

Other warnings involve severe gastrointestinal adverse reactions, delayed gastric emptying, pancreatitis, gallbladder problems, acute kidney injury related to dehydration, increased heart rate, hypoglycemia when used with certain diabetes medications, and suicidal behavior or thinking

This survey study was assigned exempt status by the Michigan State University Institutional Review Board (IRB)

GLP-1RAs GLP-1RAs are novel and encouraging therapies for HO as their mechanism of action includes targets outside of the damaged hypothalamus

Einhorn D, Stewart DA, Erman MK, Gordon N, Philis-Tsimikas A, Casal E
